Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?

Published:2019-03 Issue: Volume:34 Page:67-83
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Liu Yuxin,Bewersdorf Jan Philipp,Stahl Maximilian,Zeidan Amer M.

Funder

NCI’s Cancer Clinical Investigator Team Leadership Award

National Cancer Institute of the National Institutes of Health

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference201 articles.

1. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas;McCarthy;Iowa Orthop J.,2006

2. Graft-versus-leukemia effects of transplantation and donor lymphocytes;Kolb;Blood.,2008

3. Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future;Chen;J Clin Invest.,2015

4. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med.,2002

5. Monoclonal antibodies in multiple myeloma: a new wave of the future;Sherbenou;Clin Lymphoma Myeloma Leuk.,2017

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blockade of the TIGIT-CD155/CD112 axis enhances functionality of NK-92 but not cytokine-induced memory-like NK cells toward CD155-expressing acute myeloid leukemia;Cancer Immunology, Immunotherapy;2024-07-05

2. RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway;Cell Death & Disease;2024-07-02

3. Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice;Medical Oncology;2024-04-24

4. RSL3 enhances ROS-mediated cell apoptosis of myelodysplastic syndrome cells through MYB/Bcl-2 signaling pathway;2024-03-29

5. Targeting PRAME for acute myeloid leukemia therapy;Frontiers in Immunology;2024-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3